October 31, Monday (Day 16)
Objective: To describe post-registration activities for medicinal products
9:00-10:00 Overview
Professor Dr. Juntra Karbwang-Laothavorn, TDR/WHO, Switzerland
10:00-11:00 Post-marketing product vigilance
Dr. Yupin Lawanprasert, Ministry of Public health, Thailand
11:00-11:15 Tea break
11:15-12:15 Improving the quality of new products in health systems:
International network of rational use of drugs
Mr. Kenji Toda, Senior director, The Health Care Science Institute, Japan
12:15-13:15 Lunch
13:15-14:15 The Japanese pharmaceutical industry's growing contribution to
health in developing countries
Mr. Simon Collier, Director, Government Relations, Eisai Co., Ltd.
Chairman, IFPMA/International Cooperation Sub-Committee, Japan
14:15-15:15 Stakeholders to be involved in making product development work
for the intended beneficiaries
Dr. Yupin Lawanprasert, Ministry of Public health, Thailand
15:15-15:30 Tea break
15:30〜 Review and exam (Module 7)
Professor Dr. Kenji Hirayama and Professor Dr. Kesara Na-Bangchang